ChemNet > CAS > 1239908-20-3 Ixazomib citrate

1239908-20-3 Ixazomib citrate

Produkt-Name	Ixazomib citrate
Englischer Name	Ixazomib citrate; IXAZOMIB; IXAZOMIB CITRATE; 2,2'-(2-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diacetic acid; 2-[(1R)-1-[[2-[(2,5-Dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diacetic acid; (R)-2,2'-(2-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-5-oxo-1,3,2-dioxaborolane-4,4-diyl)diacetic acid; 2-[4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid
Molekulare Formel	C₂₀H₂₃BCl₂N₂O₉
Molecular Weight	517.12
CAS Registry Number	1239908-20-3
EINECS	C20H23BCl2N2O9
Molecular Structure
Dichte	1.47±0.1 g/cm3(Predicted)
Gefahrensymbole
Risk Codes
Safety Beschreibung

Chemicals Suppliers(1):: 1Beijing Cooperate Pharmaceutical Co.,Ltd.; Contact Suppliers; Post Buying Leads; Related selling offers